Apellis Pharmaceuticals Inc Kiemelkedően
Mi az Apellis Pharmaceuticals Inc Kiemelkedően?
A Kiemelkedően az Apellis Pharmaceuticals Inc - 121.766M
Mi a Kiemelkedően meghatározása?
A fennálló részvények egy olyan vállalat vagy pénzügyi eszköz részvényei, amelyeket a befektetők engedélyeztek, bocsátottak ki és vásároltak meg.
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Kiemelkedően a Health Care szektor a NASDAQ-on cégekben a Apellis Pharmaceuticals Inc -hoz képest
Mit csinál Apellis Pharmaceuticals Inc?
apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.
kiemelkedően -hoz hasonló cégek Apellis Pharmaceuticals Inc
- Ovato nak Kiemelkedően 121.614M van
- Ujjivan Services nak Kiemelkedően 121.614M van
- Ujjivan Services nak Kiemelkedően 121.678M van
- Abingdon Health Plc nak Kiemelkedően 121.699M van
- Abingdon Health Plc nak Kiemelkedően 121.699M van
- iHeartMedia nak Kiemelkedően 121.762M van
- Apellis Pharmaceuticals Inc nak Kiemelkedően 121.766M van
- Redfin Corp nak Kiemelkedően 121.774M van
- Voya Prime Rate Trust nak Kiemelkedően 121.775M van
- Duketon Mining nak Kiemelkedően 121.785M van
- Kintavar Exploration nak Kiemelkedően 121.858M van
- Pricol nak Kiemelkedően 121.881M van
- KB Recycling Industries Ltd nak Kiemelkedően 121.883M van